The Board proposes the development of a rule amendment to set forth conditions under which physicians do not need to keep dantrolene in office surgery facilities.

DEPARTMENT OF HEALTH
Board of Medicine

RULE NO.: RULE TITLE:
64B8-9.009: Standard of Care for Office Surgery
PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to set forth conditions under which physicians do not need to keep dantrolene in office surgery facilities.
SUBJECT AREA TO BE ADDRESSED: The clarification of conditions under which dantrolene is not necessary in office surgery settings.
RULEMAKING AUTHORITY: 458.309(1), 458.331(1)(v) FS.
LAW IMPLEMENTED: 458.331(1)(v), 458.351 FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Joy A. Tootle, Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.